Larimar Therapeutics (LRMR) Accounts Payables (2013 - 2026)
Larimar Therapeutics' Accounts Payables came in at $7.6 million for Q2 2026, up 82.2% from $4.17 million a year earlier.
Powered by 
Analysis
Larimar Therapeutics (LRMR) Accounts Payables (2013 - 2026) Analysis & Trends
At the end of FY2025, Larimar Therapeutics' Accounts Payables was $5.22 million, up 115.2% from FY2024.
- Accounts Payables carries a five-year compound annual growth rate of 14.6% (FY2020 to FY2025).
- Going back by year, Accounts Payables was $2.42 million in FY2024 (+88.9%), $1.28 million in FY2023 (-23.9%), $1.69 million in FY2022 (+1.6%) and $1.66 million in FY2021 (-37.0%).
- The five-year range for quarterly Accounts Payables is $425,000 (Q2 2022) to $11.1 million (Q3 2025).
- The fastest year-over-year change in Accounts Payables over five years came in Q3 2025 (growth of 558.4%), and the weakest in Q1 2023 (a decline of 71.2%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 9.22 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 3.83 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 4.58 Bn |
| 10 | Larimar Therapeutics | 252.95 Mn | -354.12 Mn | - | 7.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.60 Mn |
| Dec 31, 2025 | 5.22 Mn |
| Sep 30, 2025 | 11.10 Mn |
| Jun 30, 2025 | 4.17 Mn |
| Mar 31, 2025 | 2.27 Mn |
| Dec 31, 2024 | 2.42 Mn |
| Sep 30, 2024 | 1.69 Mn |
| Jun 30, 2024 | 2.92 Mn |
| Mar 31, 2024 | 1.92 Mn |
| Dec 31, 2023 | 1.28 Mn |
| Sep 30, 2023 | 756,000.00 |
| Jun 30, 2023 | 2.34 Mn |
| Mar 31, 2023 | 695,000.00 |
| Dec 31, 2022 | 1.69 Mn |
| Sep 30, 2022 | 849,000.00 |
| Jun 30, 2022 | 425,000.00 |
| Mar 31, 2022 | 2.42 Mn |
| Dec 31, 2021 | 1.66 Mn |
| Sep 30, 2021 | 1.77 Mn |
| Jun 30, 2021 | 1.46 Mn |
API Access
Larimar Therapeutics Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=LRMR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "LRMR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=LRMR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();